Working Groups
Are you interested in working in a specific topic? Now is your chance.
In the following you can find topics on which we are currently working. If you are interested in joining a Working Group, please write an email to membershipservice@esop.li
1. Development of quality standards (QuapoS)
Coordinator: Kristjan Kongi
Members: L. Bellante, P. Cavaco, C. Cortes, R. Gonec, H. Hirschinger, R. Khoueiry, A. Kokisheva, E. Korczowska, D. Lenssen, E. Moreno, G. Perego, K. Meier, R. Terkola, C. van der Merwe, N. Waheed
2. Safe working and occupational exposure (MASHA)
Coordinator: Ewelina Korczowska
Members: B. Tans , S. Aguayo Ulloa, J. Tuerk, L. Bellante, S. Casani, G. Indridadottir, R. van den Berg, M. José Tamés
Aims of the MASHA working group:
The MASHA working group aims to provide the highest standards in the safe handling of anticancer drugs and to ensure safe working conditions for all professionals involved in cancer care. The MASHA working group will work towards these aims by providing standardized working procedures in a series of recommendations that can be implemented in a working environment of the members of ESOP. The objectives will be achieved by sharing knowledge and best practices and by performing independent research.
Requirements for participants in the MASHA working group:
-Be a member of ESOP
-Be a member of their national Society
-Secure funding from their own institution or country if they want to participate in MASHA research
-Be willing to share data, knowledge and experience within ESOP
Deliverables of the MASHA working group:
- Producing concise set of recommendations that each ESOP member can use in their own institution, covering the following subjects:
-Regular environmental monitoring program
-Safe and optimized cleaning protocols
-Guidelines for acquiring and using adequate PPEs
-Annual training on safe handling of cytotoxic drugs, including spillages
-Yellow hand activity - Advancing independent research that can further build upon current MASHA studies
-Surface contamination research outside Europe
-Contamination of cytotoxic drugs packaging
-Research on internal exposure of healthcare workers to anticancer drugs
(NB: both lists can be extended by the working group)
ESOP Globals recommended laboratories for wipe sampling analysis:
The following laboratories have participated in ESOP Globals interlaboratory comparison study (Surface Wipe Sampling of Hazardous Medicinal Products: A European Interlaboratory Comparison Study – Berg – 2025 – Drug Testing and Analysis – Wiley Online Library) and are thereby officially recognised as an ESOP Global preferred laboratory for the analysis of wipe samples for cytotoxic environmental surface monitoring:
Apotheek Haagse Ziekenhuizen
Charlotte Jacobslaan 70
2545 AB Den Haag
The Netherlands
Website: https://surfacewipetest.com/
Institut für Umwelt & Energie, Technik & Analytik (IUTA)
Bliersheimer Strasse 58-60
47229 Duisburg
Germany
Website: https://www.iuta.de/ueber-iuta/
LEPABE, Porto University
R Dr Roberto Frias
4200-465 Porto
Portugal
Website: https://lepabe.fe.up.pt/
Recetox, Masaryk University
Kamenice 753/5
625 00 Brno
Czech Republic
Website: https://www.recetox.muni.cz/en
3. Compounding and GMP
Coordinator: Kristjan Kongi
4. Automation and robotization
Coordinator: Tilman Schöning
5. Biosimilars
Coordinator: Marko Skelin
6. eHealth in oncology
Coordinators: Sherif Kamal
7. Clinical Oncology Pharmacy
Coordinators: Mirjam Crul & Christophe Bardin
Members: T. Assefa, A. Balogh, L. Bellante, L. Budau, P. Cavaco, C. Cortes, D. Eppel, S. Kamal, U. Khalid, M. Kuzmanovic, D. Reyes, C. Rioufol, O. Spasovska, M. E. Uda, A. Zegrean
8. Pharmacokinetics and Therapeutic Drug Monitoring
Coordinator: Christophe Bardin
9. Research
Coordinator: Robert Terkola
10. Oral cancer drugs
Coordinator: Jelena Rosentreter
Members: A. Balogh, Z. Bodor, L. Budau, D. Eppel, S. Ferreira, F. Festinese, R. Garir, T. Hendrickx, M. Hocine, S. Kamal, N. Kizilmese, M. Kuzmanovic, K. Meier, I. Netikova, M. Saar, F. Schön, C. Schramm, E. Solarte Atacho
The Working Group (WG) “Oral Cancer Drugs” was established in 2022. We aim to increase medication safety and adherence in patients receiving oral cancer drugs. We want to enhance pharmaceutical counseling by exchanging experience and knowledge on an international level. The WG meets online approximately every three months.
Currently we are focusing on the following topics:
- which topics should be included in pharmacist education about oral cancer drugs (e.g., EUSOP programe, QUAPOS)
- which PROMs (patient reported outcomes) can be used in the field of oral cancer drugs
- entity based patient counseling
- patient information leaflets for oral cancer drugs
11. Radiopharmacy
Coordinators: Michal Budinsky & Roman Gonec
12. Paediatric cancer
Coordinator: Svetlana Buraja
Members: T. Bauters, L. Bellante, T. Bilse, G. Casper, M. Ferreira, M. Galassi, A. Gizycka, Y. Hafidi, L. Hanff, L. Horvath, S. Kamal, R. Khan, V. Ladisa, G. Lizega, K. Mache, B. Mohamed, C. Nehal, M. Ocokoljić, A. Parra Santolalla, M. Rayyan, M. Saar, F. Slimano, K. Wolber
Anno in 2017, but more practical became in 2022. We meet monthly since 2022 for interesting discussions and reports from our members, making together to do lists and planning next projects and collaborations. We communicate with SIOPE and participate in their projects and surveys. We exchange opinions, experience and sometimes analyse cases. If pediatric oncology is your field, come to our meeting and you will understant, that work in team is so much better than work alone!
Collaborations with SIOPE:
2017-2021 Read more ->
2023 Quality standards for pediatric oncology care (not published yet)
Asparaginase shortage: medicine availability, quality and safety across Europe (not published yet)
2021-2024 Read more ->
13. Pharmaceutical Technicians
Coordinaters: Claudia Woeste, Markus Dzierza
Participating Countries: Algeria, Morocco, Thaiand, Belgium, Switzerland, Spain, Hungary, Cyprus, Portugal, Austria and Germany
Group objective: Development of training materials for pharmaceutical technicians working in oncology
Start of group work:
February 12, 2025
Presentation of the curriculum developed in Germany for pharmaceutical technicians in oncology as a proposal for the development of training materials for the participating countries. The individual points will be prioritized according to their relevance to the role, and further suggestions will be made.